Atlas Trials

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy Participants

Clinical trial NCT03228433 · COMPLETED

Trial details

NCT number
NCT03228433
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2017-07-21
Primary completion
2018-05-12
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.